EPSOM Properties Ltd

Wed 2/09/2026,16:1:0 | BSE : EPSOMPRO

₹8.20-0.06 (-0.73%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 8.20

Previous Close

₹ 8.26

Volume

1026

Mkt Cap ( ₹ Cr)

₹ 6.11

High

₹ 8.20

Low

₹ 7.85

52 Week High

₹ 10.39

52 Week Low

₹ 5.41

Book Value Per Share

₹ -2.78

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on EPSOM Properties Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts EPSOM Properties Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • EPSOM Properties - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    2 Sep 2026, 5:31PM This is with reference to the captioned subject and pursuant to the provisions of Regulation 44 of Securities and Exchange Board of India (Listing Obl
  • EPSOM Properties - Shareholder Meeting / Postal Ballot-Outcome of AGM

    31 Aug 2026, 6:06PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing
  • EPSOM Properties - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    2 Sep 2026, 5:31PM This is with reference to the captioned subject and pursuant to the provisions of Regulation 44 of Securities and Exchange Board of India (Listing Obl
  • EPSOM Properties - Reg. 34 (1) Annual Report.

    28 Aug 2026, 11:30AM Please find attached Annual Report which was submitted under Corporate Announcements - Shareholders Meeting Tab on 7th August, 2026 for the records.
  • EPSOM Properties - Copy Of Annual Report Including Notice Of Annual General Meeting

    7 Aug 2026, 6:47PM Pursuant to the provisions of Regulation 34 of SEBI (Listing Obligations and Disclosure\r\nRequirements) Regulations, 2015, please find enclosed the c
  • EPSOM Properties - Copy Of Annual Report Including Notice Of Annual General Meeting

    7 Aug 2026, 6:42PM Pursuant to the provisions of Regulation 34 of SEBI (Listing Obligations and Disclosure\r\nRequirements) Regulations, 2015, please find enclosed the c
  • EPSOM Properties - Convening The 39Th Annual General Meeting (AGM) Of The Company

    5 Aug 2026, 6:16PM In line with the Ministry of Corporate Affairs (MCA) General Circular No. No 03/2025\r\ndated 22 September 2025 and the circulars issued time to time
  • EPSOM Properties - Un-Audited Financial Results For The First Quarter Ended\r\n30.06.2026

    30 Jul 2026, 6:36PM As already informed vide our letter dated 24\ July, 2026 and pursuant to the provisions of\r\nRegulation 30 read with Schedule Il Para A of Part A of
  • EPSOM Properties - Board Meeting Outcome for Un-Audited Financial Results For The First Quarter Ended 30.06.2026

    30 Jul 2026, 6:15PM As already informed vide our letter dated 24th July, 2026 and pursuant to the provisions of Regulation 30 read with Schedule III Para A of Part A of t
  • EPSOM Properties - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30.07.2026

    24 Jul 2026, 12:25PM Epsom Properties Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and
  • EPSOM Properties has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 8:00PM As of June 2026, 56.32% is owned by Foreign Promoters and 43.68% by Public. <p align=justify> Top Promoter holding highest number of shares of EPSOM P
  • EPSOM Properties - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2026, 4:36PM With reference to the above subject, we hereby submit the Certificate obtained from the Registrar and Share Transfer Agent, Cameo Corporate Services L

Key fundamentals

Evaluate the intrinsic value of EPSOM Properties Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 0.1088 0.1008 0.0889 0.0624 0.0528
Liabilities 0.1088 0.1008 0.0889 0.0624 0.0528
Equity 7.4528 7.4528 7.4528 7.4528 7.4528
Gross Profit -0.2145 -0.2359 -0.2998 -0.2641 -0.3261
Net Profit -0.3432 -0.3412 -0.3793 -0.3185 -0.3261
Cash From Operating Activities -0.3533 -0.3518 -0.4084 -0.331 -0.3436
NPM(%) 0 0 0 0 0
Revenue 0 0 0 0 0
Expenses 0.2145 0.2359 0.2998 0.2641 0.3261
ROE(%) 16.55 16.45 18.29 15.35 15.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to EPSOM Properties Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Premier Energy and Infrastructure Ltd 8.99 17.21 0.00 33.91 -2.64 0.00
Prajay Engineers Syndicate Ltd 24.66 0.65 0.00 57.35 -26.65 0.00
Sham Foam Ltd 72.00 0.49 0.00 6.87 75.28 0.00
Hubtown Ltd 181.65 0.47 27.28 111.19 104.50 0.00

Company Info

The Company was originally incorporated in the name of Tamilnadu Drugs & Pharmaceuticals Export Private Limited on 04/03/1987 as a Private Limited Company under the Indian Companies Act, 1956. The name of the Company was changed to Hulta Exports Private Limited on 17/11/1993. The name of the Company was again changed from Hulta Exports Private Limited to Hulta Exports Limited on 10/02/1995 on conversion into Public Limited Company under Section 44 of the Companies Act, 1956 with effect from 26/12/1994 and subsequently changed to Hulta Pharmaceutical Export Limited vide fresh Certificate of Incorporation consequent on change on name issued by the Registrar of Companies on 06/03/1995. The name of the Company was again changed from Hulta Pharmaceutical Export Private Limited to Epsom Properties Limited vide fresh Certificate of Incorporation consequent upon change of name issued by the Registrar of Companies on 11/05/2007. The Company has obtained the approval of the Government of India for 100% Foreign Direct Investment to carry on the business of development of serviced plots and construction of residential and commercial premises, business centres and offices, development of townships, financing of housing development, to carry on the business of city and regional level urban infrastructure facilities including roads and bridges; to carry on the business of manufacturers and distributors of all kinds of building materials and act as consultants for all kinds of goods and services pertaining to the development of properties in India and abroad and to acquire, improve, manage, develop all rights in respect of leasehold and freehold rights or properties. YEAR EVENTS 1987 - The Company was incorporated on 4th March, as a private limited company under the name of Tamilnadu Drugs and Pharmaceutical Export Pvt. Ltd. 1993 - The name of the company was changed to Hulta Export Pvt. Ltd effective 17th November. Subsequently it was converted into a public limited company and the name changed to Hulta Pharmaceutical Export Ltd. - The range of products include formulations of life saving drugs, antibacterials, antihypertensives, nasaids, antibiotics, sulpha drugs, antidiaoherial, multi vitamins etc. - The Company exports its entire product to its customers in U.K., Germany, CIS, Nigeria, Cyprus and other countries. The quality control and quality assurance facilities adopted by the company are in confirmity to WHO manufacturing practice (GMP) norms with SOP and SOMs adhered to. 2007 - Company name has been changed from HULTA PHARMACEUTICAL EXPROT LTD to EPSOM PROPERTIES LTD. 2008 -The Company designated the Email ID of the grievance redressal division / compliance officer exclusively for the purpose of registering complaints by investors is as under: tsraju07@dataone.in.

The Company was originally incorporated in the name of Tamilnadu Drugs & Pharmaceuticals Export Private Limited on 04/03/1987 as a Private Limited Company under the Indian Companies Act, 1956. The name of the Company was changed to Hulta Exports Private Limited on 17/11/1993. The name of the Company was again changed from Hulta Exports Private Limited to Hulta Exports Limited on 10/02/1995 on conversion into Public Limited Company under Section 44 of the Companies Act, 1956 with effect from 26/12/1994 and subsequently changed to Hulta Pharmaceutical Export Limited vide fresh Certificate of Incorporation consequent on change on name issued by the Registrar of Companies on 06/03/1995. The name of the Company was again changed from Hulta Pharmaceutical Export Private Limited to Epsom Properties Limited vide fresh Certificate of Incorporation consequent upon change of name issued by the Registrar of Companies on 11/05/2007. The Company has obtained the approval of the Government of India for 100% Foreign Direct Investment to carry on the business of development of serviced plots and construction of residential and commercial premises, business centres and offices, development of townships, financing of housing development, to carry on the business of city and regional level urban infrastructure facilities including roads and bridges; to carry on the business of manufacturers and distributors of all kinds of building materials and act as consultants for all kinds of goods and services pertaining to the development of properties in India and abroad and to acquire, improve, manage, develop all rights in respect of leasehold and freehold rights or properties. YEAR EVENTS 1987 - The Company was incorporated on 4th March, as a private limited company under the name of Tamilnadu Drugs and Pharmaceutical Export Pvt. Ltd. 1993 - The name of the company was changed to Hulta Export Pvt. Ltd effective 17th November. Subsequently it was converted into a public limited company and the name changed to Hulta Pharmaceutical Export Ltd. - The range of products include formulations of life saving drugs, antibacterials, antihypertensives, nasaids, antibiotics, sulpha drugs, antidiaoherial, multi vitamins etc. - The Company exports its entire product to its customers in U.K., Germany, CIS, Nigeria, Cyprus and other countries. The quality control and quality assurance facilities adopted by the company are in confirmity to WHO manufacturing practice (GMP) norms with SOP and SOMs adhered to. 2007 - Company name has been changed from HULTA PHARMACEUTICAL EXPROT LTD to EPSOM PROPERTIES LTD. 2008 -The Company designated the Email ID of the grievance redressal division / compliance officer exclusively for the purpose of registering complaints by investors is as under: tsraju07@dataone.in.

Parent Organisation

EPSOM Properties Ltd.

Founded

04/03/1987

Managing Director

NSE Symbol

FAQ